Home › Targets › mTOR

mTOR (2 companies · 9 programs)

Companies with an active program directed at mTOR.

KAZIA THERAPEUTICS LTD KZIA

  • paxalisib — Glioblastoma Phase 2
  • paxalisib — Triple-Negative Breast Cancer Phase 1
  • paxalisib — Diffuse Intrinsic Pontine Glioma Phase 2
  • paxalisib — Atypical Rhabdoid/Teratoid Tumors Phase 2
  • paxalisib — Epilepsy Phase 1
  • paxalisib — Primary Central Nervous System Lymphoma Phase 2
  • paxalisib — Brain Metastases Phase 2
  • paxalisib — IDH-Mutant Glioma Phase 2